All Stories

  1. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation
  2. Toward Single Bacterium Proteomics
  3. Multifaceted proteome analysis at solubility, redox, and expression dimensions for target identification
  4. Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies
  5. Proteomic profile of human gingival crevicular fluid reveals specific biological and molecular processes during clinical progression of periodontitis
  6. Non-typeable Haemophilus influenzae major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host
  7. Distribution, cellular localization, and colocalization of several peptide neurotransmitters in the central nervous system ofAplysia
  8. Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
  9. NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
  10. Genomic adaptation underlies nutrient-driven reprogramming in the malaria-causing parasite
  11. Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism
  12. Panomics reveals patient individuality as the major driver of colorectal cancer progression
  13. Impaired Immuno-Metabolic Homeostasis and Microenvironmental Influence on Neuropsychiatric Risk in Treated HIV Infection
  14. Brain endothelial cells exposure to malaria parasites links Type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption and cell metabolic adaptation
  15. Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
  16. Panomics reveals patient-individuality as the major driver for colorectal cancer progression
  17. Mapping the GALNT1 substrate landscape with versatile proteomics tools
  18. Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  19. Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels
  20. Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
  21. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  22. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  23. Epigenetic modulators link mitochondrial redox homeostasis to cardiac function
  24. Author response: Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  25. Nucleoside-Modified mRNA Vaccines Protect IFNAR –/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
  26. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
  27. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
  28. Mass Spectrometry-Based Analytical Strategy for Single-Cell Proteomics
  29. Ultralight ultrafast enzymes
  30. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  31. Single Cell Proteomics Using Multiplexed Isobaric Labeling for Mass Spectrometric Analysis
  32. Citrullination Alters the Antibacterial and Anti-Inflammatory Functions of the Host Defense Peptide Canine Cathelicidin K9CATH In Vitro
  33. Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection
  34. Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
  35. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
  36. Longitudinal blood cell transcriptomic profiling and in vitro temporal proteomics provides novel insights into metabolic reprogramming and host-immune responses against Crimean-Congo Hemorrhagic Fever Virus
  37. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
  38. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  39. Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
  40. EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
  41. System-wide identification and prioritization of enzyme substrates by thermal analysis
  42. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters
  43. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
  44. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  45. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target
  46. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
  47. Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
  48. Correction: S100A6 is a critical regulator of hematopoietic stem cells
  49. S100A6 is a critical regulator of hematopoietic stem cells
  50. Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  51. Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties
  52. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  53. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
  54. Current status of clinical proteogenomics in lung cancer
  55. Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell–Mediated Mechanism
  56. System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA)
  57. ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery
  58. Deuteration of human carbonic anhydrase for neutron crystallography: Cell culture media, protein thermostability, and crystallization behavior
  59. Large Scale Identification of Variant Proteins in Glioma Stem Cells
  60. In vivo Distribution of Tiotropium in a Rodent Model Utilizing AP-SMALDI Mass Spectrometry Imaging
  61. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
  62. Relationship between HMF intake and SMF formation in vivo: An animal and human study
  63. Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
  64. Novel insights in drug metabolism by MS imaging
  65. Mutant Proteogenomics
  66. Proteogenomics
  67. Drug localizations in tissue by mass spectrometry imaging
  68. In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins
  69. Drug compound characterization by mass spectrometry imaging in cancer tissue
  70. Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project
  71. Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes
  72. Association of chromosome 19 to lung cancer genotypes and phenotypes
  73. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study
  74. Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging
  75. Use of ENCODE Resources to Characterize Novel Proteoforms and Missing Proteins in the Human Proteome
  76. Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins
  77. SC-23 * THE ROLE OF SINGLE AMINO ACID POLYMORPHISMS IN GLIOMA STEM CELL PHENOTYPES
  78. A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging
  79. Aptamer/ISET-MS: A New Affinity-Based MALDI Technique for Improved Detection of Biomarkers
  80. Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development
  81. Queries of MALDI-imaging global datasets identifying ion mass signatures associated with tissue compartments
  82. Identification of Missing Proteins: Toward the Completion of Human Proteome
  83. Integrated Chromosome 19 Transcriptomic and Proteomic Data Sets Derived from Glioma Cancer Stem-Cell Lines
  84. Developments in biobanking workflow standardization providing sample integrity and stability
  85. Experimental Models to Study Drug Distributions in Tissue Using MALDI Mass Spectrometry Imaging
  86. Accessing microenvironment compartments in formalin-fixed paraffin-embedded tissues by protein expression analysis
  87. Quantification of Human Kallikrein-2 in Clinical Samples by Selected Reaction Monitoring
  88. Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring
  89. Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction
  90. Blood Plasma Reference Material: A Global Resource for Proteomic Research
  91. Correlation Queries for Mass Spectrometry Imaging
  92. Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
  93. International biobanking for lung cancer and COPD as the future resource for clinical protein research
  94. Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
  95. A Critical Evaluation of Inflammatory Markers in Huntington's Disease Plasma
  96. Clinical and Biomedical Mass Spectrometry: New Frontiers in Drug Developments and Diagnosis
  97. Chromosome 19 Annotations with Disease Speciation: A First Report from the Global Research Consortium
  98. Large scale biobanking of blood — The importance of high density sample processing procedures
  99. Standardization and Utilization of Biobank Resources in Clinical Protein Science with Examples of Emerging Applications
  100. Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry
  101. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
  102. Clinical Proteomics
  103. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
  104. Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
  105. MRM assay for quantitation of complement components in human blood plasma — a feasibility study on multiple sclerosis
  106. State-of-the-art MS technology applications in lung disease
  107. Direct Demonstration of Tissue Uptake of an Inhaled Drug: Proof-of-Principle Study Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging
  108. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging
  109. Biobank resources for future patient care: developments, principles and concepts
  110. Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
  111. Clinical Protein Science and Bioanalytical Mass Spectrometry with an Emphasis on Lung Cancer
  112. Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry
  113. Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
  114. Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples
  115. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
  116. Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis
  117. Identification of novel candidate protein biomarkers for the post-polio syndrome — Implications for diagnosis, neurodegeneration and neuroinflammation
  118. General Approach for Certain Quantitative Calculations for Instance of the Variance of Reversible Adsorption to the Capillary Wall in CE
  119. Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology
  120. Activity of the Small Modified Amino Acid α-Hydroxy Glycineamide on In Vitro and In Vivo Human Immunodeficiency Virus Type 1 Capsid Assembly and Infectivity
  121. Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort
  122. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses and cells (bacteria). Ib. Gel antibodies against...
  123. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses, and cells (bacteria). III: Gel antibodies again...
  124. Theoretical and nomenclatural considerations of capillary electrochromatography with monolithic stationary phases
  125. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis
  126. Homogeneous gels for capillary electrochromatography
  127. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis
  128. Chapter 10 Technologies interfacing capillary electrophoresis to mass spectrometry
  129. Chapter 3 Peptide and protein separations by capillary electrophoresis and electrochromatography
  130. 2 Evolution and development of isoelectric focusing
  131. Hybrid microdevice electrophoresis of peptides, proteins, DNA, viruses, and bacteria in various separation media, using UV-detection
  132. High-Resolution Capillary Zone and Gel Electrophoresis of Structurally Similar Amphipathic Glutathione Conjugates Based on Interaction with -Cyclodextrins
  133. Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis
  134. A hybrid microdevice for electrophoresis and electrochromatography using UV detection
  135. Stable homogeneous gel for molecular-sieving of DNA fragments in capillary electrophoresis
  136. Enantioseparation of hydroxy acids on easy-to-prepare continuous beds for capillary electrochromatography
  137. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  138. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  139. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  140. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  141. (Normal-phase) capillary chromatography using acrylic polymer-based continuous beds
  142. Chiral separation of α-amino acids by ligand-exchange capillary electrophoresis usingN-(2-hydroxy-octyl)-L-4-hydroxyproline as a selector
  143. New set-up for capillary isoelectric focusing in uncoated capillaries